Advertisement
U.S. Markets close in 1 hr 30 mins

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
189.85+0.85 (+0.45%)
As of 02:30PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close189.00
Open188.55
Bid0.00 x 0
Ask0.00 x 0
Day's Range187.71 - 190.06
52 Week Range181.31 - 268.30
Volume338,494
Avg. Volume1,102,043
Market Cap27.653B
Beta (5Y Monthly)-0.06
PE Ratio (TTM)23.91
EPS (TTM)7.94
Earnings DateOct 30, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est263.90
  • Investor's Business Daily

    Is Eli Lilly Stock A Buy After Snagging Approval For A New Eczema Drug?

    The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?

  • Benzinga

    After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce

    On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorganization is intended to enable Sage to strengthen its balance sheet, extend its cash runway, and position the company for long-term growth potential. The reorganization is planned to be substantially completed by the end of the fourth quarter of 2024. The company will lay off over 165 employee